Back to search
FDAFDA · Food and drugs·Recall number D-829-2013

Ranitidine Syrup (Ranitidine Oral Solution USP) 15 mg/mL, Rx Only. Manufactured by VistaPharm, Inc., Birmingham, AL 35242. Distributed by Actavis Mid Atlantic LLC 1877 Kawai Road, Lincolnton, NC 28092 USA

Published August 7, 2013 · Recall initiated: May 15, 2013

Summary

FDA records drug Class II recall D-829-2013, published August 7, 2013 and initiated May 15, 2013. Recalling firm: Actavis South Atlantic LLC; Status: Terminated; Reported quantity: A total of 133,968 bottles (units); Lot: Lot Numbers: 247900, 251000, 256000, 261200, 263600, 266700, 277100, 280300 and 284300. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Impurity/Degradation Specification; "Related Compound C"

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Actavis South Atlantic LLC
Distributor
Nationwide
Lot
Lot Numbers: 247900, 251000, 256000, 261200, 263600, 266700, 277100, 280300 and 284300.
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Ranitidine Syrup (Ranitidine Oral Solution USP) 15 mg/mL, Rx Only. Manufactured by VistaPharm, Inc., Birmingham, AL 35242. Distributed by Actavis Mid Atlantic LLC 1877 Kawai Road, Lincolnton, NC 28092 USA recalled?

Yes. FDA published recall D-829-2013 on August 7, 2013. Reported hazard: Failed Impurity/Degradation Specification; "Related Compound C"

What should I do if I have this product?

Voluntary: Firm initiated · Letter